Dynamin GTPase (3.6.5.5)

Industry

CPC
C12Y306/05005

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12YENZYMES C12Y306/00Hydrolases acting on acid anhydrides (3.6)

Current Industry

C12Y306/05005Dynamin GTPase (3.6.5.5)

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Allele-specific silencing therapy for dynamin 2-related diseases
- Patent number 11,926,829
- Issue date Mar 12, 2024
- ASSOICATION INSTITUT DE MYOLOGIE
- Marc Bitoun
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Dynamin 2 inhibitor for the treatment of centronuclear myopathies
- Patent number 11,499,155
- Issue date Nov 15, 2022
- Universite de Strasbourg
- Jocelyn Laporte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene sequence of recombinant human type II mitochondrial dynein-lik...
- Patent number 11,459,584
- Issue date Oct 4, 2022
- Wuhan Neurophth Biotechnology Limited Company
- Bin Li
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Designing customized protein-specific buffer system
- Patent number 11,001,872
- Issue date May 11, 2021
- Shawn Clark
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Allele-specific silencing therapy for Dynamin 2-related diseases
- Patent number 10,947,540
- Issue date Mar 16, 2021
- ASSOCIATION INSTITUT DE MYOLOGIE
- Marc Bitoun
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Dynamin 2 inhibitor for the treatment of Duchenne's muscular dystrophy
- Patent number 10,822,400
- Issue date Nov 3, 2020
- Universite de Strasbourg
- Jocelyn Laporte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dynamin 2 inhibitor for the treatment of centronuclear myopathies
- Patent number 10,647,986
- Issue date May 12, 2020
- Universite de Strasbourg
- Jocelyn Laporte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Dynamin mediated diseases and associated methods and products
- Patent number 8,668,927
- Issue date Mar 11, 2014
- The General Hospital Corporation
- Jochen Reiser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dynamin mediated diseases and associated methods and products
- Patent number 7,670,817
- Issue date Mar 2, 2010
- The General Hospital Corporation
- Jochen Reiser
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING OCULAR DISEASES AND DISORDERS
- Publication number 20240269326
- Publication date Aug 15, 2024
- Abeona Therapeutics Inc.
- Linas PADEGIMAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALLELE-SPECIFIC SILENCING THERAPY FOR DYNAMIN 2-RELATED DISEASES
- Publication number 20240229039
- Publication date Jul 11, 2024
- ASSOCIATION INSTITUT DE MYOLOGIE
- Marc BITOUN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF OPTIC ATROPHY
- Publication number 20230407310
- Publication date Dec 21, 2023
- PYC Therapeutics Limited
- Fred Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF CENTRONUCLEAR MYOPATHIES
- Publication number 20230203497
- Publication date Jun 29, 2023
- UNIVERSITE DE STRASBOURG
- JOCELYN LAPORTE
- G01 - MEASURING TESTING
Information Patent Application
DESIGNING CUSTOMIZED PROTEIN-SPECIFIC-BUFFER SYSTEM
- Publication number 20220106620
- Publication date Apr 7, 2022
- Shawn Clark
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING CENTRONUCL...
- Publication number 20210322562
- Publication date Oct 21, 2021
- Dyne Therapeutics, Inc.
- Romesh R. Subramanian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ALLELE-SPECIFIC SILENCING THERAPY FOR DYNAMIN 2-RELATED DISEASES
- Publication number 20210163953
- Publication date Jun 3, 2021
- ASSOCIATION ISNTITUT DE MYOLOGIE
- Marc BITOUN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF DUCHENNE'S MUSCULAR DYSTROPHY
- Publication number 20210130447
- Publication date May 6, 2021
- UNIVERSITE DE STRASBOURG
- JOCELYN LAPORTE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF CENTRONUCLEAR MYOPATHIES
- Publication number 20200308589
- Publication date Oct 1, 2020
- UNIVERSITE DE STRASBOURG
- JOCELYN LAPORTE
- G01 - MEASURING TESTING
Information Patent Application
Designing Customized Protein-Specific Buffer System
- Publication number 20180282782
- Publication date Oct 4, 2018
- DELTA TM TECHNOLOGIES
- Shawn CLARK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF DUCHENNE'S MUSCULAR DYSTROPHY
- Publication number 20180142008
- Publication date May 24, 2018
- UNIVERSITE DE STRASBOURG
- JOCELYN LAPORTE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF CENTRONUCLEAR MYOPATHIES
- Publication number 20160264976
- Publication date Sep 15, 2016
- UNIVERSITE DE STRASBOURG
- JOCELYN LAPORTE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DYNAMIN MEDIATED DISEASES AND ASSOCIATED METHODS AND PRODUCTS
- Publication number 20100221317
- Publication date Sep 2, 2010
- The General Hospital Corporation
- Jochen Reiser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGENTS FOR PROPHYLAXIS OR TREATMENT OF NEUROLOGICAL RELATED DISEASE...
- Publication number 20080306007
- Publication date Dec 11, 2008
- NEWCASTLE INNOVATION LIMITED
- Adam McCluskey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dynamin mediated diseases and associated methods and products
- Publication number 20070197438
- Publication date Aug 23, 2007
- The General Hospital Corporation
- Jochen Reiser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Dynamin GTPase (3.6.5.5)

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Allele-specific silencing therapy for dynamin 2-related diseases

Dynamin 2 inhibitor for the treatment of centronuclear myopathies

Gene sequence of recombinant human type II mitochondrial dynein-lik...

Designing customized protein-specific buffer system

Allele-specific silencing therapy for Dynamin 2-related diseases

Dynamin 2 inhibitor for the treatment of Duchenne's muscular dystrophy

Dynamin 2 inhibitor for the treatment of centronuclear myopathies

Dynamin mediated diseases and associated methods and products

Dynamin mediated diseases and associated methods and products

Patents Applicationslast 30 patents

METHODS AND COMPOSITIONS FOR TREATING OCULAR DISEASES AND DISORDERS

ALLELE-SPECIFIC SILENCING THERAPY FOR DYNAMIN 2-RELATED DISEASES

TREATMENT OF OPTIC ATROPHY

DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF CENTRONUCLEAR MYOPATHIES

DESIGNING CUSTOMIZED PROTEIN-SPECIFIC-BUFFER SYSTEM

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING CENTRONUCL...

ALLELE-SPECIFIC SILENCING THERAPY FOR DYNAMIN 2-RELATED DISEASES

DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF DUCHENNE'S MUSCULAR DYSTROPHY

DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF CENTRONUCLEAR MYOPATHIES

Designing Customized Protein-Specific Buffer System

DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF DUCHENNE'S MUSCULAR DYSTROPHY

DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF CENTRONUCLEAR MYOPATHIES

DYNAMIN MEDIATED DISEASES AND ASSOCIATED METHODS AND PRODUCTS

AGENTS FOR PROPHYLAXIS OR TREATMENT OF NEUROLOGICAL RELATED DISEASE...

Dynamin mediated diseases and associated methods and products